Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,293 total articles
Mark W. Jenkins, the Chief Financial Officer of Carvana Co. (NASDAQ: CVNA), executed a series of transactions involving the company's Class A Common Stock on July 1, 2026. The activities include the sale of 63,750 shares under a Rule 10b5-1 trading plan, the exercise of stock options for an equivalent number of shares, and the disposition of additi…
Verisign Inc. (NASDAQ: VRSN) Executive Vice President Thomas C. Indelicarto executed a sale of company equity on July 1, 2026, disposing of 250 shares at $255.83 each for a total value of $63,957. The transaction reduces his direct holdings to 36,301.0439 shares, with no derivative activity reported. This sale occurs as Verisign trades near $256.43…
Randall H. Frazier, a director at Optical Cable Corp (NASDAQ:OCC), executed a strategic divestment of 10,000 shares, realizing $210,055 from the transaction on June 16, 2026. This insider activity occurs against a backdrop of significant stock price volatility, recent financial improvements, and expanded market index inclusion.
Alan J. Russell, the Chief Scientific Officer of Edgewise Therapeutics, Inc. (NASDAQ:EWTX), executed a substantial sale of company shares on July 1, 2026, netting approximately $7.88 million. This transaction follows a period of significant stock appreciation and recent clinical trial updates for the company's hypertrophic cardiomyopathy drug candi…
Randall H. Frazier, a director at Optical Cable Corp (NASDAQ:OCC), executed a sale of 35,000 shares on June 11, 2026, totaling $865,686. The transaction, initially misclassified in a Form 4 filing, was corrected to reflect a disposal of common stock. Shares were sold at prices between $24.1273 and $26.635, near the stock’s 52-week high of $27.98. F…
Robert I. Blum, President and Chief Executive Officer of Cytokinetics Inc. (NASDAQ:CYTK), executed a sale of 7,500 shares of the company’s common stock on July 1, 2026. The transaction, valued at approximately $636,900 at a price of $84.92 per share, was conducted under a Rule 10b5-1 trading plan. Following this sale, Mr. Blum retains direct owners…
Fergal Stack, Senior Vice President and Corporate Controller at Happen, Inc., executed a sale of 50,000 shares of the company’s common stock on July 1, 2026. The transaction, valued at $1,050,690, was conducted under a Rule 10b5-1 trading plan. The sale occurred at a price range of $21.00 to $21.05 per share, with a weighted-average price of $21.01…
Aaron James Deer, Executive Vice President and Chief Strategy and Innovation Officer at Columbia Banking System, Inc., executed a $22,477 purchase of 886 shares at $25.37 per share on June 30, 2026, through the company's employee stock purchase plan. Following this transaction, his direct holdings total 42,761 shares. The acquisition occurs as the …
Andrew Callos, Executive Vice President and Chief Commercial Officer at Cytokinetics Inc. (NASDAQ:CYTK), executed a significant transaction involving the sale of 15,000 common shares on July 1, 2026. This activity followed the simultaneous exercise of non-qualified stock options for an equivalent number of shares. The sale occurred at a price of $8…
Neville Patrick Sean, a director at Circle Internet Group, Inc. (NASDAQ:CRCL), executed a sale of 50,000 Class A Common Stock shares on July 1, 2026, valued at $3,132,444. The transaction was facilitated under a pre-established 10b5-1 trading plan. Prior to the sale, Mr. Neville converted an equivalent number of Class B shares into Class A shares, …
Jordan Cheng, serving as both General Counsel and Secretary for Happen Inc. (NASDAQ:HAPN), executed a sale of 5,500 shares of the company's common stock on July 1, 2026. The transaction, valued at $114,693, occurred at prices between $20.62 and $20.95 per share. This activity coincides with the company's recent rebranding from LendingClub to Happen…
Optical Cable Corp (NASDAQ:OCC) director Craig H. Weber executed a significant stock sale on June 29, 2026, liquidating 24,300 shares for $470,406. The transaction, clarified through an amended Form 4 filing, occurred after a period of extraordinary stock appreciation, despite internal valuation metrics suggesting the shares are trading above their…
Optical Cable Corp (NASDAQ:OCC) Chairman, President and CEO Neil D. Wilkin Jr. has executed a sale of common stock valued at $532,916. The transaction, completed across June 29 and June 30, 2026, involves the disposition of 25,000 shares. This insider selling activity occurs against a backdrop of substantial recent stock price appreciation and a no…
Jon Ayotte, EverQuote's Chief Accounting Officer, sold 4,611 shares of the company's Class A Common Stock on July 1, 2026, as part of a Rule 10b5-1 trading plan. The transaction was executed at $24.15 per share, totaling $111,355. Ayotte also had 1,538 shares withheld to cover tax obligations related to restricted stock unit vesting. Following the …
Seacoast Banking Corporation of Florida (NASDAQ:SBCF) director Dennis S. Hudson, III executed a sale of 4,000 common shares on July 1, 2026, under a Rule 10b5-1 trading plan. The transaction, valued at $136,000, was priced at $34.00 per share, reflecting a premium over the stock's recent trading levels. The sale was facilitated through a pre-establ…
Wang Feng-Ming, chief executive officer of Ambarella Inc., completed a divestment of 16,250 ordinary shares on July 1, 2026, generating approximately $1,463,800. The transactions were executed under a Rule 10b5-1 trading plan established on October 8, 2025, at prices between $90.00 and $90.50 per share, yielding a weighted average sale price of $90…
Peter A. Thompson, a director at Sionna Therapeutics, Inc. (NASDAQ: SION), executed a sale of common stock valued at approximately $5.27 million, according to a report filed on June 30, 2026. The transaction involved the disposal of 115,844 shares at $45.50 per share. While SION shares currently trade at $43.99, the sale comes against a backdrop of…
FedEx Corp. (NASDAQ: FDX) director Paul S. Walsh executed a structured equity transaction on June 30, 2026, selling 5,042 shares valued at approximately $1.64 million while simultaneously exercising an equivalent number of stock options. The dual transaction reflects standard option exercise mechanics following the June 1, 2026, spin-off of FedEx F…
Gabriel M.I. Mecklenburg, serving as Executive Chairman and Co-Founder of Hinge Health, Inc. (NASDAQ:HNGE), executed a substantial divestment of company equity on July 1, 2026. The transaction involved the sale of 83,334 shares of Class A Common Stock, valued at approximately $7.09 million. This sale was preceded by the conversion of an equivalent …
Mid Penn Bancorp Inc. (NASDAQ: MPB) director Albert J. Evans recently executed a $9,999 purchase of the company's common stock on June 30, 2026. The transaction occurred at $34.84 per share, positioning Evans' holdings near the stock's 52-week peak of $35.75. This insider activity follows Mid Penn Bancorp's first-quarter financial report, which sho…
SentinelOne Inc. (NASDAQ: S) Chief Executive Officer Tomer Weingarten executed a strategic divestment of 57,941 Class A common shares, realizing approximately $1.02 million in proceeds. This transaction, processed on July 1, 2026, was conducted under a Rule 10b5-1 trading plan established in June 2025, ensuring compliance with regulatory frameworks…
Mid Penn Bancorp Inc. (NASDAQ: MPB) director Robert A. Abel executed a purchase of company common stock, according to a recent SEC Form 4 filing. The acquisition coincides with the release of the company's first-quarter financial results and a new analyst rating, providing a snapshot of insider activity against a backdrop of mixed earnings performa…
Lightbridge Corp (NASDAQ:LTBR) director Sweta Chakraborty sold 1,143 shares of the company’s common stock on July 1, 2026, for a total value of $10,618. The transaction was executed at prices ranging from $9.24 to $9.31 per share, with a weighted average price of $9.29. This sale was conducted under a Rule 10b5-1 trading plan adopted by Ms. Chakrab…
Andrew Merriman, Chief Operating Officer of Castellum, Inc., executed a purchase of 1,202 shares of company common stock on July 1, 2026. The transaction, valued at $735, was facilitated through the Castellum, Inc. 2025 Employee Stock Purchase Plan. The acquisition price of $0.612 per share represented a 15% discount to the stock's closing price on…
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Chief Medical Officer Sarah Gheuens executed a sale of 4,007 shares on July 1, 2026, generating $150,502 in proceeds to cover tax withholding obligations tied to restricted stock unit vesting. The transaction occurred under a pre-established Rule 10b5-1 trading plan initiated in July 2023. Concurrently, Agi…
